# Adipose Tissue After Switch to Doravirine

> **NCT05477407** · NA · COMPLETED · sponsor: **Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida** · enrollment: 22 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine

## Key facts

- **NCT ID:** NCT05477407
- **Lead sponsor:** Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-06
- **Primary completion:** 2024-03-15
- **Final completion:** 2025-01-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477407, "Adipose Tissue After Switch to Doravirine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05477407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*